Related content

Plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients undergoing autologous stem cell transplantation

By Moreb Jan  

Oncology Reviews, Vol. 5, Iss. 1, 2011-03 ,pp. : 67-73

Springer Publishing Company

Access to resources Recommend Favorite

Novel agent induction therapy alone or followed by autologous stem cell transplantation in younger patients with multiple myeloma: A singlecenter retrospective study of 114 cases

By                

Molecular and Clinical Oncology, Vol. 4, Iss. 1, 2016-01 ,pp. : 107-113

Science Publishers

Access to resources Recommend Favorite

Multiple myeloma with extramedullary plasmacytoma invading the skin and eyeballs following autologous stem cell transplantation: A case report

By          

Experimental and Therapeutic Medicine, Vol. 6, Iss. 4, 2013-01 ,pp. : 883-886

Spandidos Publications

Access to resources Recommend Favorite

Health-Related Quality of Life in Multiple Myeloma Patients Receiving High-Dose Chemotherapy with Autologous Blood Stem-Cell Support

By Gulbrandsen N.   Wisløff F.   Brinch L.   Carlson K.   Dahl I.M.   Gimsing P.   Hippe E.   Hjorth M.   Knudsen L.M.   Lamvik J.   Lenhoff S.   Løfvenberg E.   Nesthus I.   Lanng Nielsen J.   Turesson I.   Westin J.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 65-77

Humana Press, Inc

Access to resources Recommend Favorite

Analysis of long‐term survival in multiple myeloma after first‐line autologous stem cell transplantation: impact of clinical risk factors and sustained response

By  

Cancer Medicine, Vol. 7, Iss. 2, 2018-02 ,pp. : 307-316

John Wiley & Sons Inc

Access to resources Recommend Favorite